Use of dihydromyricetin (DMY) as an NF-κB inhibitor or an IKK-β inhibitor for the treatment of arthritis, cancer, autoimmune conditions and other disease is provided. A pharmaceutical composition comprising DMY is also provided.
[Detail]
This invention is in the field of pharmaceuticals, health supplements, health supplements, and chemical industries. In particular, this invention relates to Huanglian-Jie-Du-Tang (HLJDT), which is a famous traditional Chinese herbal formula that has been widely used clinically to treat cerebral isch.....
[Detail]
The present invention relates to methods and an apparatus for developing, analyzing, investigating, supporting and advising healthcare and well-being related decisions.
[Detail]
The present invention is directed to method of preventing or treating neural disease such as Alzheimer’s disease or inhibiting accumulation of β-amy-loid plaques in a subject by administering an effective dosage to the subject an agent (berberine) which inhibits the accumulation of β-amy-loid plaque.....
[Detail]
This invention relates to a chemical entity isolated from natural sources for itstherapeutic uses. More particularly, it relates to a compound that is naturally occurring inthe plant of Garcinia esculenta and its biological activity of antitumor effects.
[Detail]
| |< <- | [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] | -> >| |
